1-(3-溴丙氧基)-2-氯苯 | 50912-59-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 1-(3-溴丙氧基)-2-氯苯
• 中文别名: 1-(3-溴丙基)-2-氯苯
• 英文名称: 1-(3-bromo-propoxy)-2-chloro-benzene
• 英文别名: 1-(3-Bromopropoxy)-2-chlorobenzene
• CAS: 50912-59-9
• 化学式: C₉H₁₀BrClO
• 分子量: 249.535
• InChiKey: GRPVXZDDHARJSD-UHFFFAOYSA-N

物化性质

• 沸点：
  156-166 °C (16 mmHg)
• 闪点：
  160 °C
• 稳定性/保质期：
  遵照规定使用和储存，则不会发生分解。

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险品标志：
  Xn
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R20/22,R36/37/38
• 海关编码：
  2909309090
• 储存条件：
  存于阴凉干燥处。

SDS

Name:	1-(3-Bromopropoxy)-2-chlorobenzene Material Safety Data Sheet
Synonym:
CAS:	50912-59-9

Section 1 - Chemical Product MSDS Name:1-(3-Bromopropoxy)-2-chlorobenzene Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
50912-59-9	1-(3-Bromopropoxy)-2-chlorobenzene		unlisted

Hazard Symbols: XN
Risk Phrases: 20/22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation and if swallowed. Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 50912-59-9: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 156 - 166 deg C @16mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: 160 deg C ( 320.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: >160 deg C
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H10BrClO
Molecular Weight: 249.53

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, carbon dioxide, hydrogen bromide.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 50912-59-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-(3-Bromopropoxy)-2-chlorobenzene - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2810
Packing Group: III
IMO
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing Group: III
RID/ADR
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/22 Harmful by inhalation and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 50912-59-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 50912-59-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 50912-59-9 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-(3-溴丙氧基)-2-氯苯 在 sodium azide 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 2.5h， 生成 1-(2-azidopropoxy)-2-chlorobenzene
  参考文献：
  名称：

  Novel Synthetic Strategy of N-Arylated Heterocycles via Sequential Palladium-Catalyzed Intra- and Inter-Arylamination Reactions

  摘要：

  描述了一种使用原位生成的Pd(0)催化剂，该催化剂与N,N′-双（2,6-二异丙基苯基）二氢咪唑-2-亚基（SIPr）作为配体，以及t-BuONa作为碱，进行顺序的分子内和分子间芳基氨化的方法。这种方法已应用于合成N-芳基化的五、六和七元氮杂环。

  DOI：

  10.1055/s-2004-831205
• 作为产物：
  描述：

  邻氯苯酚 、 1,3-二溴丙烷 在 sodium hydride 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 1.5h， 以46%的产率得到1-(3-溴丙氧基)-2-氯苯
  参考文献：
  名称：

  通过螺硼酸盐催化还原纯 (E)-和 (Z)-O-苄基肟非外消旋伯胺的不对称合成：在拟钙剂合成中的应用

  摘要：

  使用衍生自稳定的螺硼酸酯，通过硼烷介导的单一异构体 ( E )- 和 ( Z ) -O-苄基肟醚的还原，合成了高对映体纯的 (1-芳基)-和 (1-萘基)-1-乙胺( S )-二苯基缬氨醇和乙二醇作为手性催化剂。伯 ( R )-芳基乙胺是通过使用 15% 的催化剂将纯 ( Z )-乙酮肟醚还原至 99% ee来制备的。描述了使用对映纯(1-萘-1-基)乙胺作为手性前体合成新的和已知的拟钙剂类似物的两种方便且容易的方法。

  DOI：

  10.1021/jo400371x

文献信息

• 3,4,5-Substituted piperidines as therapeutic compounds
  申请人：Herold Peter

  公开号：US20070167433A1

  公开（公告）日：2007-07-19

  Use of compounds of the general formula (I) and pharmaceutically acceptable salt thereof, in which R 1 , R 2 , R 3 , R 4 , W, X and Z, n and m have the definitions illustrated in detail in the description, as beta-secretase, cathepsin D, plasmepsin II and/or HIV protease inhibitors.

  在一般式（I）及其药用可接受盐中使用具有详细定义的R1、R2、R3、R4、W、X和Z、n和m的化合物，作为β-分泌酶、半胱氨酸蛋白酶D、质粒蛋白酶II和/或HIV蛋白酶抑制剂。
• N-Heterocyclic carbene–chromium-catalyzed alkylative cross-coupling of benzamide derivatives with aliphatic bromides
  作者：Jinghua Tang、Pei Liu、Xiaoming Zeng

  DOI：10.1039/c8cc05026k

  日期：——

  Described here is a chromium-catalyzed alkylative cross-coupling of benzamide derivatives with aliphatic electrophiles under mild conditions. This reaction was promoted by a low-cost and air-stable chromium(III) chloride salt combined with an N-heterocyclic carbene ligand and phenylmagnesium bromide as a reductant, and probably occurred with low-valent chromium involved in the catalytic cleavage of

  这里描述的是在温和条件下苯甲酰胺衍生物与脂肪族亲电子试剂的铬催化烷基化交叉偶联。低成本，空气稳定的氯化铬（III）盐与N-杂环卡宾配体和苯基溴化镁作为还原剂的结合促进了该反应，并且可能发生在低价铬参与邻位催化裂解的过程中苯甲酰胺的-C–H键，然后通过涉及自由基的机理与烷基溴偶联。
• [EN] ORGANIC COMPOUNDS<br/>[FR] COMPOSES ORGANIQUES
  申请人：SPEEDEL EXPERIMENTA AG

  公开号：WO2005061457A1

  公开（公告）日：2005-07-07

  Novel substituted piperidines of the general formulae (I) and (II) with the substituent definitions as explained in detail in the description are described. The compounds are suitable in particular as renin inhibitors and are highly potent.

  描述了一种具有一般式(I)和(II)的新型替代哌啶化合物，其中详细说明了取代基定义。这些化合物特别适用作为肾素抑制剂，并且具有很高的效力。
• Discovery of Carboline Derivatives as Potent Antifungal Agents for the Treatment of Cryptococcal Meningitis
  作者：Jie Tu、Zhuang Li、Yanjuan Jiang、Changjin Ji、Guiyan Han、Yan Wang、Na Liu、Chunquan Sheng

  DOI：10.1021/acs.jmedchem.8b01598

  日期：2019.3.14

  novel chemical scaffolds and new modes of action is of great importance. Herein, new β-hexahydrocarboline derivatives are shown to possess potent anticryptococcal activities. In particular, compound A4 showed potent in vitro and in vivo anticryptococcal activity with good metabolic stability and blood-brain barrier permeability. Compound A4 was orally active and could significantly reduce brain fungal

  由于缺乏有效和安全的药物疗法，隐球菌性脑膜炎（CM）的临床治疗仍然是一项重大挑战。开发具有新型化学支架和新作用方式的新型CM治疗剂非常重要。在此，新的β-六烃基衍生物显示出具有有效的抗隐球菌活性。特别地，化合物A4显示出有效的体外和体内抗隐球菌活性，具有良好的代谢稳定性和血脑屏障通透性。化合物A4具有口服活性，可在CM鼠模型中显着减轻脑部真菌的负担。此外，化合物A4可以抑制新型隐球菌的几种毒力因子，并可能以新的作用方式起作用。初步的机理研究表明，化合物A4通过作用于Cdc25c / CDK1 / cyclin B途径，诱导了DNA双链断裂和细胞周期阻滞在G2期。综上所述，β-六烃基A4代表了开发下一代CM治疗剂的有前途的先导化合物。
• Novel indole derivatives
  申请人：H. Lundbeck A/S

  公开号：US20030050307A1

  公开（公告）日：2003-03-13

  The invention provide compounds of the formula 1 wherein X represents O or S; n is 2, 3, 4, 5, 6, 7, 8, 9 or 10; m is 2 or 3; Y represents N, C or CH; and the dotted line represents an optional bond; R 1 , R 1′ , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and R 12 are as defined in the description. The compounds are ligands of the 5-HT 1a -receptor.

  该发明提供了化合物的公式1，其中X代表O或S；n为2、3、4、5、6、7、8、9或10；m为2或3；Y代表N、C或CH；虚线代表可选键；R1、R1'、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11和R12如描述中所定义。这些化合物是5-HT1a受体的配体。